Literature DB >> 15847211

Cyclophosphamide restores heart function in a patient with lupus myocarditis.

Zaher S Azzam1, Itay Maza, Tawfiq Zeidan-Shwiri, Margalit Lorber.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15847211

Source DB:  PubMed          Journal:  Isr Med Assoc J            Impact factor:   0.892


× No keyword cloud information.
  2 in total

1.  Low-dose oral cyclophosphamide therapy reduces atherosclerosis progression by decreasing inflammatory cells in a murine model of atherosclerosis.

Authors:  Yayoi Sato-Okabayashi; Kikuo Isoda; Beate Heissig; Tomoyasu Kadoguchi; Koji Akita; Kenichi Kitamura; Kazunori Shimada; Koichi Hattori; Hiroyuki Daida
Journal:  Int J Cardiol Heart Vasc       Date:  2020-05-10

Review 2.  Management of cardiovascular disease in patients with systemic lupus erythematosus.

Authors:  Paramarjan Piranavan; Andras Perl
Journal:  Expert Opin Pharmacother       Date:  2020-06-08       Impact factor: 3.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.